Newspaper publication about Financial Results for Q4 FY26 published in Pratah Kaal, Marathi Newspaper
CNL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The BSE filing by Creative Newtech Ltd publishes Sanjivani Parenteral Limited's Q4 FY26 audited financial results. For Q4 FY26 (standalone), total revenue was Rs 138.09 lakh with EBITDA of Rs 21.73 lakh (15.74% margin) and net profit after tax of Rs 5.48 lakh (3.97% margin), translating to EPS of Rs 0.49 per share. For the full year FY26 (standalone), revenue declined to Rs 6,975.64 lakh from Rs 7,131.21 lakh in FY25, while net profit fell to Rs 669.38 lakh from Rs 809.43 lakh. The company cited temporary market adjustments and production challenges that impacted quarterly performance, and said it completed trial production of raw materials worth ~Rs 6 crore. Pune facility has started commercial operations with an initial trial order of ~USD 0.5 million. Management improved cost efficiency by 242 bps through rationalising employee and operational expenses.
Full-year revenue and profit declined year-on-year, with Q4 standalone PAT dropping sharply, signalling near-term headwinds. However, the Pune facility launch and raw material export potential offer future growth catalysts. Shareholders should monitor if the cost reduction measures and new product development translate into margin recovery in FY27.